Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomach Neoplasms 24Colorectal Neoplasms 12Colonic Neoplasms 9Rectal Neoplasms 6Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Esophageal Squamous Cell Carcinoma 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Biliary Tract Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Gallbladder Neoplasms 3Esophageal Neoplasms 3HER2-positive Gastric Cancer 2Cholangiocarcinoma 2Uterine Cervical Neoplasms 1Stage IA Pancreatic Adenocarcinoma 1Solid Tumor 1Recurrence 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Malignant Neoplasms of Digestive Organs 1Lung Neoplasms 1Klatskin Tumor 1Immunotherapy 1Gastric Adenocarcinoma 1Fruquintinib 1For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method 1

Interventions

Rituximab 10Valganciclovir 6Etoposide 4Doxorubicin 4Valacyclovir 3Gemcitabine 3Dexamethasone 3Cyclophosphamide 3Cisplatin 3spartalizumab 2pembrolizumab 2pegaspargase 2Zidovudine 2Vincristine 2Radiotherapy, Intensity-Modulated 2Prednisone 2Methylprednisolone 2Methotrexate 2Matrix-M 2Leucovorin 2Lenalidomide 2Cell Count 2Carboplatin 2Blood Specimen Collection 2Acyclovir 2valomaciclovir 1toripalimab 1threonic acid 1ruxolitinib 1pomalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Tegafur × Clear all
NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

National Health Research Institutes, Taiwan

Phase 3 Terminated
10 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡